Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan

Added by globalcompliancepanel on 2018-01-04

Conference Dates:

Start Date Start Date: 2018-02-08
Last Date Last Day: 2018-02-09
Deadline for abstracts/proposals Deadline for abstracts/proposals: 2018-02-06

Conference Contact Info:

Contact Person Contact Person: Event manager
Email Email: [email protected]
Address Address: Courtyard Arlington Crystal City/Reagan National Airport, Washington, DC, United States
Phone Tel: 800-447-9407
Phone Fax: 302-288-6884

Conference Description:

Global Medical Device Regulations continue to evolve, as devices become more diverse and sophisticated. Understanding the regulations and requirements in your targeted markets will expedite speed-to-market of innovative products and assist patients needing access to life-saving products and technologies. Government Regulatory Authorities, needing to become more efficient with their time, are looking for ways to better use their internal resources without compromising safety in products, which become marketable. One such example is the Medical Device Single Audit Program [MDSAP], where Authorized Organizations would be allowed to carry out a single GMP audit on medical device manufacturing facilities and have it stand to support registrations across the current participating member countries: U.S. Canada, Brazil, Australia and Japan.

Why you should attend:
This two-day seminar is focused on understanding the Medical Device Single Audit Program, the scope of the program, how to apply, the Authorized Organizations, the rating system developed and what you can expect when signing onto the program. The seminar will discuss how such audits are organized, what to expect during a MDSAP audit, how does this differ from a typical certified body audit, along with document movement and timeline expectations in receiving the facility's certificate.

The key Regulatory Requirements for Medical Devices will also be covered for the participating MDSAP Countries of: U.S., Canada, Brazil, Australia and Japan.

Areas Covered in the Session:
The Medical Device Single Audit Program (MDSAP)
Device Classification
Licensing Pathways
Medical Device GMP
Inspections
Device Labeling
License Holder Responsibilities
Timelines and Fees
Country Specific Cultural Considerations and Challenges
Adverse Event Reporting
Who Will Benefit:
This two-day seminar will provide invaluable assistance to all personnel in the Medical Device industry, who have a stake in expanding their business into a MDSAP participating country and for those interested in more information about MDSAP and how it may apply to them.

This seminar will be particularly useful for those involved in research and development, document creation for regulatory submission, data handling and for those conducting/monitoring/coordinating clinical investigation, performing risk management and post-market vigilance/surveillance. This seminar is a must for those who are looking to apply for a medical device registration and product license in a MDSAP country.

Read More: http://www.globalcompliancepanel.com/con trol/globalseminars/~product_id=901160SE MINAR?worldconferencecalendar-February-2 018-SEO
© 2022 World Conference Calendar. All rights reserved.